Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Losartan"" wg kryterium: Temat


Tytuł:
The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats.
Autorzy:
Siregar S; Department of Urology, Universitas Padjadjaran, Bandung, 40161, Indonesia.
Rulianov R; Department of Urology, Universitas Padjadjaran, Bandung, 40161, Indonesia.
Ksatriapraja RA; Department of Urology, Universitas Padjadjaran, Bandung, 40161, Indonesia.
Stefanus D; Department of Urology, Universitas Padjadjaran, Bandung, 40161, Indonesia.
Pokaż więcej
Źródło:
F1000Research [F1000Res] 2024 Feb 06; Vol. 11, pp. 831. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/pharmacology
Losartan*/therapeutic use
Priapism*/pathology
Humans ; Male ; Rats ; Animals ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Rats, Wistar ; Transforming Growth Factor beta1/metabolism ; Angiotensin-Converting Enzyme Inhibitors ; Penis ; Fibrosis ; Collagen
Czasopismo naukowe
Tytuł:
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis.
Autorzy:
Snyman JR; Clinical Pharmacologist, Pretoria, South Africa.
Gumedze F; Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
Jones ESW; Division of Nephrology and Hypertension, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Alaba OA; Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Tsabedze N; Division of Cardiology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand and The Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Vira A; Quantium Health South Africa, Johannesburg, South Africa.
Ntusi NAB; Division of Cardiology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, J46.53, Old Main Building, Main Road, Observatory, Cape Town, 7925, South Africa. .
Pokaż więcej
Źródło:
Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 5076-5089. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Losartan*/therapeutic use
Losartan*/pharmacology
Hypertension*/complications
Humans ; Antihypertensive Agents/therapeutic use ; Enalapril/therapeutic use ; Enalapril/pharmacology ; Perindopril/therapeutic use ; South Africa/epidemiology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Blood Pressure
Czasopismo naukowe
Tytuł:
Vascular injury associated with ethanol intake is driven by AT1 receptor and mitochondrial dysfunction.
Autorzy:
Awata WMC; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Alves JV; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Costa RM; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Bruder-Nascimento A; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA.
Singh S; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA.
Barbosa GS; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA; UNIPEX, Medical School, Sao Paulo State University (UNESP), Botucatu, Brazil.
Tirapelli CR; School of Nursing of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Bruder-Nascimento T; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Center for Pediatrics Research in Obesity and Metabolism (CPROM), University of Pittsburgh, Pittsburgh, PA, USA; Endocrinology Division at UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA; Vascular Medicine, Institute (VMI), University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec 31; Vol. 169, pp. 115845. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/pharmacology
Vascular System Injuries*
Humans ; Mice ; Male ; Animals ; Receptor, Angiotensin, Type 1/metabolism ; Ethanol/toxicity ; Hydrogen Peroxide/metabolism ; Reactive Oxygen Species/metabolism ; Mitochondria/metabolism
Czasopismo naukowe
Tytuł:
Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A comparison of VANISH and INHERIT randomized trials.
Autorzy:
Severinsen T; Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: tino_.
Thune JJ; Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Gudmundsdottir HL; Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Vissing CR; Department of Cardiology, The Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Iversen K; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Copenhagen University Hospital-Herlev-Gentofte, Copenhagen, Denmark.
Ho CY; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Bundgaard H; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, The Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Axelsson Raja A; Department of Cardiology, The Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
American heart journal [Am Heart J] 2023 Dec; Vol. 266, pp. 198-200. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Cardiomyopathy, Hypertrophic*/drug therapy
Losartan*/therapeutic use
Humans ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Challenges in the transfer and scale-up of mini-tableting: Case study with losartan potassium.
Autorzy:
Lura V; Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany. Electronic address: .
Klinken S; Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany.
Breitkreutz J; Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany.
Pokaż więcej
Źródło:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2023 Nov; Vol. 192, pp. 161-173. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*
Excipients*
Tablets ; Tensile Strength ; Drug Compounding/methods ; Powders
Czasopismo naukowe
Tytuł:
Allisartan Isoproxil Promotes Uric Acid Excretion by Interacting with Intestinal Urate Transporters in Hyperuricemic Zebrafish (Danio rerio).
Autorzy:
Xiao Y; Shenzhen Salubris Pharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Miao Z; Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, Guangdong, China.
Sun J; Shenzhen Salubris Pharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Xing W; Shenzhen Salubris Pharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Wei Y; Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, Guangdong, China.
Bai J; Shenzhen Salubris Pharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Ye H; Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, Guangdong, China.
Si Y; Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, Guangdong, China.; College of Life Science and Engineering, Foshan University, Foshan, Guangdong, China.
Cai L; Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2023 Sep; Vol. 175 (5), pp. 638-643. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/pharmacology
Losartan*/metabolism
Hyperuricemia*/drug therapy
Hyperuricemia*/genetics
Hyperuricemia*/metabolism
Animals ; Uric Acid/metabolism ; Zebrafish/metabolism ; Kidney/metabolism
Czasopismo naukowe
Tytuł:
Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC-PDA.
Autorzy:
Wani TU; Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Kashmir, India.
Mir KB; Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Kashmir, India.
Raina A; Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu Tawi, India.
Dar AA; Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, India.
Jan I; Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, India.
Khan NA; Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Kashmir, India.
Wani TA; Department of Analytical Chemistry, Guindy Campus, University of Madras, Chennai, India.
Sofi JA; Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, India.
Hassan GI; Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, India.
Almoallim HS; Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Alharbi SA; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Ansari MJ; Department of Botany, Hindu College Moraabad (Mahatma Jyotiba Phule Rohilkhand University Bareilly), Moradabad, India.
Alfarraj S; Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
Tarique M; Almanac Life Science India Private Limited, New Delhi, India.
Dar SA; Faculty of Forestry, Sher-e-Kashmir University of Agricultural Sciences and Technology, Ganderbal, India.
Pokaż więcej
Źródło:
Biomedical chromatography : BMC [Biomed Chromatogr] 2023 Aug; Vol. 37 (8), pp. e5645. Date of Electronic Publication: 2023 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/analysis
Animals ; Rabbits ; Chromatography, High Pressure Liquid/methods ; Valsartan ; Quality Control ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits.
Autorzy:
Sampaio LP; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Ophthalmology at University of Sao Paulo, Sao Paulo, Brazil.
Villabona-Martinez V; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Shiju TM; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Santhiago MR; Department of Ophthalmology at University of Sao Paulo, Sao Paulo, Brazil.
Wilson SE; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Translational vision science & technology [Transl Vis Sci Technol] 2023 Sep 01; Vol. 12 (9), pp. 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Losartan*/pharmacology
Corneal Opacity*/drug therapy
Rabbits ; Animals ; Myofibroblasts ; Vimentin ; Collagen Type IV
Czasopismo naukowe
Tytuł:
Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure.
Autorzy:
Martínez-Arias L; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Fernández-Villabrille S; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Alonso-Montes C; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
García-Navazo G; Departamento de Química Orgánica y Química Inorgánica, Instituto de Investigación Química 'Andrés M. del Río' (IQAR), Universidad de Alcalá (IRYCIS), 28805 Alcalá de Henares, Spain.
Ruíz-Torres MP; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.; Physiology Unit, Department of Systems Biology, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Área 3-Fisiología y Fisiopatología Renal y Vascular del Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Reina Sofía de Investigación Nefrológica (IRSIN) de la Fundación Renal Iñigo Álvarez de Toledo (FRIAT), 28871 Alcalá de Henares, Spain.
Alajarín R; Departamento de Química Orgánica y Química Inorgánica, Instituto de Investigación Química 'Andrés M. del Río' (IQAR), Universidad de Alcalá (IRYCIS), 28805 Alcalá de Henares, Spain.
Alvarez-Builla J; Departamento de Química Orgánica y Química Inorgánica, Instituto de Investigación Química 'Andrés M. del Río' (IQAR), Universidad de Alcalá (IRYCIS), 28805 Alcalá de Henares, Spain.
Gutiérrez-Calabres E; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.; Physiology Unit, Department of Systems Biology, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Área 3-Fisiología y Fisiopatología Renal y Vascular del Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Reina Sofía de Investigación Nefrológica (IRSIN) de la Fundación Renal Iñigo Álvarez de Toledo (FRIAT), 28871 Alcalá de Henares, Spain.
Vaquero-López JJ; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.; Departamento de Química Orgánica y Química Inorgánica, Instituto de Investigación Química 'Andrés M. del Río' (IQAR), Universidad de Alcalá (IRYCIS), 28805 Alcalá de Henares, Spain.
Carrillo-López N; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Rodríguez-Puyol D; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.; Physiology Unit, Department of Systems Biology, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Área 3-Fisiología y Fisiopatología Renal y Vascular del Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Reina Sofía de Investigación Nefrológica (IRSIN) de la Fundación Renal Iñigo Álvarez de Toledo (FRIAT), 28871 Alcalá de Henares, Spain.; Departamento de Medicina, Universidad de Alcalá, Servicio de Nefrología, Hospital Universitario Príncipe de Asturias, 28871 Alcalá de Henares, Spain.
Cannata-Andía JB; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Panizo S; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Naves-Díaz M; Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, 33011 Oviedo, Spain.; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28040 Madrid, Spain.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2023 Apr 10; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/pharmacology
Losartan*/therapeutic use
Kidney Failure, Chronic*
Rats ; Male ; Animals ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Tumor Necrosis Factor-alpha/pharmacology ; Rats, Wistar ; Models, Theoretical ; Fibrosis ; Kidney/metabolism
Czasopismo naukowe
Tytuł:
The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review.
Autorzy:
Yamaura K; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: .
Nelson AL; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA. Electronic address: .
Nishimura H; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; Department of Orthopaedic Surgery, University Hospital of Occupational and Environmental Health, Fukuoka, Japan. Electronic address: .
Rutledge JC; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA. Electronic address: .
Ravuri SK; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA. Electronic address: .
Bahney C; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; The Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, USA. Electronic address: .
Philippon MJ; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA; The Steadman Clinic, Vail, CO, USA. Electronic address: .
Huard J; Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, USA. Electronic address: .
Pokaż więcej
Źródło:
Osteoarthritis and cartilage [Osteoarthritis Cartilage] 2023 Apr; Vol. 31 (4), pp. 435-446. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Losartan*/pharmacology
Losartan*/therapeutic use
Osteoarthritis*
Animals ; Humans ; Angiotensin II Type 2 Receptor Blockers ; Angiotensin Receptor Antagonists ; Cartilage
Czasopismo naukowe
Tytuł:
Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
Autorzy:
Patel R; Department of Quality Assurance, Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar, India.
Purohit S; Department of Quality Assurance, Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar, India.
Solanki R; Department of Quality Assurance, Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar, India.
Khunt D; Department of Pharmaceutics, Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar, India.
Patel C; Department of Medicinal Chemistry, Shri Sarvajanik Pharmacy College, Mehsana, India.
Patel R; Regulatory Affairs Division, JAMP INDIA Pharmaceutical Pvt. Ltd., Ahmedabad, India.
Parikh S; Analytical Development Division, Senores Pharmaceuticals, Ahmedabad, India.
Pokaż więcej
Źródło:
Rapid communications in mass spectrometry : RCM [Rapid Commun Mass Spectrom] 2023 Apr 30; Vol. 37 (8), pp. e9488.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Losartan*/analysis
Losartan*/chemistry
Nitrosamines*
Humans ; Hydrochlorothiazide/chemistry ; Chromatography, High Pressure Liquid/methods ; Tandem Mass Spectrometry/methods ; Chromatography, Liquid ; Tablets
Czasopismo naukowe
Tytuł:
IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation.
Autorzy:
Mansour RSH; Faculty of pharmacy, Philadelphia University, Amman, Jordan.
Al Khawaja AY; School of pharmacy, University of Jordan, Amman, Jordan.
Hamdan II; School of pharmacy, University of Jordan, Amman, Jordan.
Khalil EA; School of pharmacy, University of Jordan, Amman, Jordan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jun 15; Vol. 18 (6), pp. e0287267. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Losartan*/pharmacology
Leukemia, Myeloid, Acute*/drug therapy
Humans ; Salts/metabolism ; Amlodipine ; Pharmaceutical Preparations/chemistry ; Keratins/metabolism ; Skin/metabolism
Czasopismo naukowe
Tytuł:
Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.
Autorzy:
Liu B; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Road, Guangzhou 510120, China.
Jie X; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Road, Guangzhou 510120, China.
Deng J; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China.
Zhang S; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China.
Lu F; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Road, Guangzhou 510120, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Liu X; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Road, Guangzhou 510120, China. Electronic address: .
Zhang D; The Second Clinical College of Guangzhou University of Chinese Medicine, No.111 Dade Road, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Road, Guangzhou 510120, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2023 Jun; Vol. 114, pp. 154767. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Losartan*/pharmacology
Renal Insufficiency, Chronic*
Rats ; Humans ; Animals ; Kidney ; Fatty Acids/metabolism ; Fibrosis
Czasopismo naukowe
Tytuł:
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.
Autorzy:
Eworuke E; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA .
Shinde M; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Hou L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Paterson MJ; Canadian Network for Observational Drug Effect Studies (CNODES), Montréal, Quebec, Canada.
Jensen PB; University of Southern Denmark, Odense, Denmark.
Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Rai A; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Scarnecchia D; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pennap D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Woronow D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Ghosh RE; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory, London, UK.
Welburn S; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory, London, UK.
Pottegard A; Hospital Pharmacy, Odense Universitetshospital, Odense, Denmark.; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
Platt RW; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Lee H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Bradley MC; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Apr 17; Vol. 13 (4), pp. e070985. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Losartan*/therapeutic use
Hypertension*
Humans ; Irbesartan/therapeutic use ; Valsartan/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Retrospective Studies ; Cohort Studies ; Tetrazoles/therapeutic use ; Biphenyl Compounds/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors ; Canada ; Denmark ; United Kingdom
Czasopismo naukowe
Tytuł:
Angiotensinergic neurotransmission in the bed nucleus of the stria terminalis is involved in cardiovascular responses to acute restraint stress in rats.
Autorzy:
Gomes-de-Souza L; Laboratory of Pharmacology, Department of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Santana FG; Laboratory of Pharmacology, Department of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Duarte JO; Laboratory of Pharmacology, Department of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Barretto-de-Souza L; Laboratory of Pharmacology, Department of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Crestani CC; Laboratory of Pharmacology, Department of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil. .
Pokaż więcej
Źródło:
Pflugers Archiv : European journal of physiology [Pflugers Arch] 2023 Apr; Vol. 475 (4), pp. 517-526. Date of Electronic Publication: 2023 Jan 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Losartan*/pharmacology
Septal Nuclei*
Rats ; Animals ; Rats, Wistar ; Captopril/pharmacology ; Heart Rate/physiology ; Synaptic Transmission
Czasopismo naukowe
Tytuł:
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.
Autorzy:
Scholtes RA; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Mosterd CM; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Hesp AC; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Smits MM; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
van Raalte DH; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Jan; Vol. 25 (1), pp. 198-207. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Losartan*/pharmacology
Losartan*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Middle Aged ; Aged ; Blood Pressure ; Cross-Over Studies ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Serum Albumin
Czasopismo naukowe
Tytuł:
Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy.
Autorzy:
Sun J; Department of Orthopaedics, The First Affiliated Hospital of Jishou University, The People's Hospital of Xiangxi Autonomous Prefecture, Jishou, China.
Zhang C; Department of Jishou University, Jishou, China.
Su X; Department of Jishou University, Jishou, China.
Zhou H; Department of Medicine, Taizhou University, Zhejiang, China.
Zhou S; Department of Medicine, Taizhou University, Zhejiang, China.
Jiang M; Department of Medicine, Taizhou University, Zhejiang, China.
Fang B; Department of Medicine, Taizhou University, Zhejiang, China. .
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Feb 19; Vol. 19 (1), pp. 147. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/drug therapy
Fibrosarcoma*/drug therapy
Humans ; Antihypertensive Agents/therapeutic use ; Losartan/pharmacology ; Losartan/therapeutic use ; Captopril/pharmacology ; Captopril/therapeutic use ; Spironolactone/therapeutic use ; Furosemide/therapeutic use ; CD8-Positive T-Lymphocytes ; Hydrochlorothiazide/therapeutic use ; Drug Therapy, Combination ; Verapamil/pharmacology ; Verapamil/therapeutic use ; Solute Carrier Family 12, Member 3
Czasopismo naukowe
Tytuł:
A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol.
Autorzy:
Anggraini YE; Faculty of Medicine, Universitas Riau, Kota Pekanbaru, Indonesia.; Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Trisnowati N; Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Martien R; Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Danarti R; Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 02; Vol. 25 (1), pp. 12. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Keloid*/diagnosis
Keloid*/drug therapy
Adult ; Humans ; Triamcinolone Acetonide/adverse effects ; Losartan/adverse effects ; Angiotensin II/therapeutic use ; Treatment Outcome ; Injections, Intralesional ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Oxidative stress enhances rotavirus oncolysis in breast cancer and leukemia, except in melanoma with abundant matrix.
Autorzy:
Guerrero M; Departamento de Ciencias Fisiológicas, Facultad de Medicina, Universidad Nacional de Colombia, DC, Bogotá, Colombi.
Hernández J; Grupo de Fisiología Molecular del Instituto Nacional de Salud. A. A. 80080. Av. Calle 26 No. 51-20 DC, Bogotá, Colombia.
Gomez L; Departamento de Ciencias Fisiológicas, Facultad de Medicina, Universidad Nacional de Colombia, DC, Bogotá, Colombi; Grupo de Fisiología Molecular del Instituto Nacional de Salud. A. A. 80080. Av. Calle 26 No. 51-20 DC, Bogotá, Colombia.
Guerrero C; Departamento de Ciencias Fisiológicas, Facultad de Medicina, Universidad Nacional de Colombia, DC, Bogotá, Colombi. Electronic address: .
Pokaż więcej
Źródło:
Virus research [Virus Res] 2024 Jan 02; Vol. 339, pp. 199285. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/therapy
Breast Neoplasms*
Rotavirus*/genetics
Rotavirus*/metabolism
Rotavirus Infections*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Humans ; Female ; Reactive Oxygen Species/metabolism ; Losartan/pharmacology ; Losartan/therapeutic use ; Cell Line, Tumor ; Apoptosis ; Oxidative Stress
Czasopismo naukowe
Tytuł:
ANGPT2/CAV1 regulates albumin transcytosis of glomerular endothelial cells under high glucose exposure and is impaired by losartan.
Autorzy:
Chen Y; Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li H; Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhang D; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Gong Y; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Jiang H; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Sun H; Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: .
Wang Y; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: .
Pokaż więcej
Źródło:
Nefrologia [Nefrologia (Engl Ed)] 2024 Jan-Feb; Vol. 44 (1), pp. 50-60. Date of Electronic Publication: 2023 Feb 25.
Typ publikacji:
Journal Article
MeSH Terms:
Caveolin 1*/metabolism
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/metabolism
Humans ; Mice ; Animals ; Endothelial Cells/metabolism ; Losartan/pharmacology ; Albuminuria/drug therapy ; Albuminuria/metabolism ; Angiopoietin-2/metabolism ; Transcytosis ; Albumins/metabolism ; Glucose/pharmacology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies